http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
재조합조직플라즈미노겐활성제의 신경세포독성에 대한 혈관내피성장인자 발현을 통한 Statin의 보호효과
정중택,안진영,한문구 대한뇌졸중학회 2010 Journal of stroke Vol.12 No.2
Background: Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) has proven beneficial for acute stroke management. However, rt-PA might also have toxicity on neuronal and endothelial viability. 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) has pluripotent actions and beneficial microvascular effect beyond its primary role of reducing serum lipids. The purpose of this study is to investigate the role of statin in reducing human neuronal cell deaths by rt-PA toxicity in an in vitro ischemic condition. Methods: Human cortical-neuroblastoma hybrid cell line (A1G11) was incubated in hypoxic chamber (951% O2). rt-PA (50 μg/mL) was treated as a toxic agent and simvastatin (10 μM) were administered to investigate its protective effect for the rt-PA toxicity 12 hours before rt-PA treatment. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, Thiazolyl Blue Tetrazolium Bromide] assay was performed to measure the cell viabilities. Vascular endothelial growth factor (VEGF) expression was measured by Western blots. Results: In an in vitro ischemic condition, the cell viability was decreased and VEGF immunoreactivity was increased. Statin increased VEGF immunoreactivity. An addition of rt-PA treatment in hypoxic condition reduced significantly the cell viability (P<0.05) and VEGF immunoreactivities. Simvastatin pretreatment increased VEGF immunoreactivity after 6 hours (P<0.05) and the cell viability after 6 hours in A1G11 (P=0.023 at 6 h, P=0.002 at 12 h, P=0.019 at 18 h). Conclusion: These data suggest that statin might reduce rt-PA-induced neuronal cell deaths via an increment of VEGF expression and be helpful to protect neuronal cells in acute ischemic stroke with rt-PA.